Second-line treatment with oxaliplatin + raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapy. [electronic resource]
Producer: 20011204Description: 709-14 p. digitalISSN:- 0923-7534
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Camptothecin -- analogs & derivatives
- Colorectal Neoplasms -- drug therapy
- Disease Progression
- Disease-Free Survival
- Drug Resistance, Neoplasm
- Female
- Fluorouracil -- pharmacology
- Humans
- Irinotecan
- Leucovorin -- pharmacology
- Male
- Middle Aged
- Neutropenia -- chemically induced
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
- Quinazolines -- administration & dosage
- Salvage Therapy
- Thiophenes -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.